Drug application
ESOMEPRAZOLE MAGNESIUM;NAPROXEN (ESOMEPRAZOLE MAGNESIUM;NAPROXEN)
Drugs@FDA ANDA 202767 · ANCHEN PHARMS
Key facts
| Drug name | ESOMEPRAZOLE MAGNESIUM;NAPROXEN |
|---|---|
| Active ingredients | ESOMEPRAZOLE MAGNESIUM;NAPROXEN |
| Application type | ANDA |
| Application number | 202767 |
| Company | ANCHEN PHARMS |
| Dosage forms | UNKNOWN |
| Strength | UNKNOWN |
| Marketing status | None (Tentative Approval) |
| Reference listed drug | No |
| Latest submission status date | Feb 27, 2019 |
At a glance
- 1–9 Submissions
- None Label versions
- None Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.